InsiderGauge
Checking updates…
Dashboard

ABUSArbutus Biopharma Corp

Market cap
$643.76M
as of 2026-10-23
Latest close
$4.20
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2024-02-05

Dashed line = amended filing (Form 4/A)

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Sawhney RogerOct 1Oct 7D17,142$5.00$85,71013,683NoForm 4
Androski LindsayPresident and CEOOct 1Oct 7D24,655$5.00$123,27547,682NoForm 4
Beardsley Robert AOct 1Oct 7D17,948$5.00$89,74014,328NoForm 4
Nguyen TuanChief Financial OfficerOct 1Oct 7D48,081$5.00$240,405111,882NoForm 4
Roivant Sciences Ltd.Oct 1Oct 5D8,967,383$5.00$44,836,91529,880,079NoForm 4
Beardsley Robert ASep 18Sep 23M52,533$3.20$168,10652,533NoForm 4
Beardsley Robert ASep 18Sep 23M78,800$4.24$334,112131,333NoForm 4
Beardsley Robert ASep 18Sep 23F99,057$5.07$502,21932,276NoForm 4
Beardsley Robert ASep 18Sep 23M · derivative52,533$3.20$168,106105,067NoForm 4
Beardsley Robert ASep 18Sep 23M · derivative78,800$4.24$334,112not reportedNoForm 4
Sawhney RogerSep 18Sep 23M52,533$3.34$175,46052,533NoForm 4
Sawhney RogerSep 18Sep 23M78,800$4.24$334,112131,333NoForm 4
Sawhney RogerSep 18Sep 23F100,508$5.07$509,57630,825NoForm 4
Sawhney RogerSep 18Sep 23M · derivative52,533$3.34$175,460105,067NoForm 4
Sawhney RogerSep 18Sep 23M · derivative78,800$4.24$334,112not reportedNoForm 4
Nguyen TuanChief Financial OfficerSep 18Sep 23M265,625$3.49$927,031339,125NoForm 4
Nguyen TuanChief Financial OfficerSep 18Sep 23M27,475$4.39$120,615366,600NoForm 4
Nguyen TuanChief Financial OfficerSep 18Sep 23F206,637$5.07$1,047,650159,963NoForm 4
Nguyen TuanChief Financial OfficerSep 18Sep 23M · derivative265,625$3.49$927,031484,375NoForm 4
Nguyen TuanChief Financial OfficerSep 18Sep 23M · derivative27,475$4.39$120,615160,925NoForm 4
Androski LindsayPresident and CEOSep 18Sep 23M116,408$3.20$372,506144,408NoForm 4
Androski LindsayPresident and CEOSep 18Sep 23M10,456$4.39$45,902154,864NoForm 4
Androski LindsayPresident and CEOSep 18Sep 23F82,527$5.07$418,41272,337NoForm 4
Androski LindsayPresident and CEOSep 18Sep 23M · derivative116,408$3.20$372,506194,014NoForm 4
Androski LindsayPresident and CEOSep 18Sep 23M · derivative10,456$4.39$45,90261,244NoForm 4
Beardsley Robert AJun 8Jun 10A · derivative78,800$4.24$334,11278,800NoForm 4
Sawhney RogerJun 8Jun 10A · derivative78,800$4.24$334,11278,800NoForm 4
Androski LindsayPresident and CEOFeb 2Feb 2A28,000$0.00$028,000NoForm 4
Androski LindsayPresident and CEOFeb 2Feb 2A · derivative71,700$4.39$314,76371,700NoForm 4
Nguyen TuanChief Financial OfficerFeb 2Feb 2A73,500$0.00$073,500NoForm 4
Nguyen TuanChief Financial OfficerFeb 2Feb 2A · derivative188,400$4.39$827,076188,400NoForm 4
Sawhney RogerAug 4, 2025Aug 6, 2025A · derivative157,600$3.34$526,384157,600NoForm 4
Nguyen TuanChief Financial OfficerMar 31, 2025Apr 1, 20254/AA · derivative750,000$3.49$2,617,500750,000NoForm 4/A
Androski LindsayPresident and CEOMar 18, 2025Mar 20, 2025A · derivative310,422$3.20$993,350310,422NoForm 4
Beardsley Robert AMar 18, 2025Mar 20, 2025A · derivative157,600$3.20$504,320157,600NoForm 4
Hasija AnujMar 18, 2025Mar 20, 2025A · derivative157,600$3.20$504,320157,600NoForm 4
Sims KarenChief Medical OfficerFeb 14, 2025Feb 19, 2025A49,300$0.00$0155,494NoForm 4
Sims KarenChief Medical OfficerFeb 14, 2025Feb 19, 2025A · derivative200,300$3.29$658,987200,300NoForm 4
Hastings David CChief Financial OfficerFeb 14, 2025Feb 19, 2025A90,100$0.00$0249,824NoForm 4
Hastings David CChief Financial OfficerFeb 14, 2025Feb 19, 2025A · derivative365,800$3.29$1,203,482365,800NoForm 4
McElhaugh Michael J.Interim President & CEOFeb 14, 2025Feb 19, 2025A177,000$0.00$01,658,003NoForm 4
McElhaugh Michael J.Interim President & CEOFeb 14, 2025Feb 19, 2025A · derivative718,800$3.29$2,364,852718,800NoForm 4
Naftzger J. ChristopherGeneral Counsel and CCOFeb 14, 2025Feb 19, 2025A54,300$0.00$0140,544NoForm 4
Naftzger J. ChristopherGeneral Counsel and CCOFeb 14, 2025Feb 19, 2025A · derivative220,300$3.29$724,787220,300NoForm 4
Naftzger J. ChristopherGeneral Counsel and CCOFeb 4, 2025Feb 5, 2025S11,333$3.28Sale −$37,17286,244YesForm 4
McElhaugh Michael J.Interim President & CEOFeb 4, 2025Feb 5, 2025S23,790$3.28Sale −$78,0311,481,003YesForm 4
Sims KarenChief Medical OfficerFeb 4, 2025Feb 5, 2025S19,348$3.28Sale −$63,461106,194YesForm 4
Hastings David CChief Financial OfficerFeb 4, 2025Feb 5, 2025S22,183$3.28Sale −$72,760159,724YesForm 4
Manchester Keith SAug 14, 2024Aug 16, 2024M54,915$0.56$30,75254,915NoForm 4
Manchester Keith SAug 14, 2024Aug 16, 2024S8,846$3.69Sale −$32,64246,069NoForm 4
Manchester Keith SAug 14, 2024Aug 16, 2024M · derivative54,915$0.56$30,752not reportedNoForm 4
Torti FrankMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
Rewolinski MelissaMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
Meyers James RMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
Henriques Richard C JrMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
Manchester Keith SMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
Burgess Daniel DMay 23, 2024May 24, 2024A · derivative67,000$3.28$219,76067,000NoForm 4
McElhaugh Michael J.Interim President & CEOFeb 2, 2024Feb 5, 2024S10,164$2.31Sale −$23,4791,504,793YesForm 4
Sofia Michael J.Chief Scientific OfficerFeb 2, 2024Feb 5, 2024S9,982$2.31Sale −$23,0581,485,121YesForm 4
Hastings David CChief Financial OfficerFeb 2, 2024Feb 5, 2024S9,593$2.31Sale −$22,160181,907YesForm 4
Sims KarenChief Medical OfficerFeb 2, 2024Feb 5, 2024S4,358$2.31Sale −$10,067125,542YesForm 4
McElhaugh Michael J.Interim President & CEOFeb 1, 2024Feb 5, 2024A123,800$0.00$01,514,957YesForm 4
McElhaugh Michael J.Interim President & CEOFeb 1, 2024Feb 5, 2024A · derivative495,100$2.40$1,188,240495,100YesForm 4
Sofia Michael J.Chief Scientific OfficerFeb 1, 2024Feb 5, 2024A109,500$0.00$01,495,103YesForm 4
Sofia Michael J.Chief Scientific OfficerFeb 1, 2024Feb 5, 2024A · derivative437,800$2.40$1,050,720437,800YesForm 4
Hastings David CChief Financial OfficerFeb 1, 2024Feb 5, 2024A112,500$0.00$0191,500YesForm 4
Hastings David CChief Financial OfficerFeb 1, 2024Feb 5, 2024A · derivative450,000$2.40$1,080,000450,000YesForm 4
Sims KarenChief Medical OfficerFeb 1, 2024Feb 5, 2024A101,000$0.00$0129,900YesForm 4
Sims KarenChief Medical OfficerFeb 1, 2024Feb 5, 2024A · derivative403,900$2.40$969,360403,900YesForm 4
Naftzger J. ChristopherGeneral Counsel and CCOFeb 1, 2024Feb 5, 2024A95,100$0.00$095,100NoForm 4
Naftzger J. ChristopherGeneral Counsel and CCOFeb 1, 2024Feb 5, 2024A · derivative380,500$2.40$913,200380,500NoForm 4